IMO this has touched the bottom of its trend. Trials well advanced. A director buying, albeit small volumes.All very good signs. Time to double up.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025